(Q44367391)

English

The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms

scientific article published on 19 March 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Roberto W Invernizzi

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Claudio Garavaglia

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Rosario Samanin

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

19 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

872-879

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Behavioral and biochemical interactions of 5,7-dihydroxy-tryptamine with various drugs when administered intracisternally to adult and developing rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Studies on RX 781094: a selective, potent and specific antagonist of α2-adrenoceptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Idazoxan treatment in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

The effect of serotonergic agents on haloperidol-induced catalepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

The role of alpha2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

The alpha 2-adrenoceptor antagonist idazoxan is an agonist at 5-HT1A autoreceptors modulating serotonin synthesis in the rat brain in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Noradrenaline inhibits central serotonin release through alpha 2-adrenoceptors located on serotonergic nerve terminals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

21 January 2018

Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonergic involvement with neuroleptic catalepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of reserpine rigidity by alpha-2 adrenergic antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300119

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300119

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44367391&oldid=2206595921"